GV
Investor profile
Venture capital
GV has backed 36 European tech companies across 45 funding rounds between 2017 and 2026, joining rounds totalling €5.4B. Most active in Healthtech and Software. Data as of Nov 2026.
Deals
45
distinct rounds
Companies
36
backed
Active span
2017–2026
10 yrs
Total round €
€5.4B
sum of rounds joined
Deals by year
distinct rounds / yearGV — deals by year — interactive chart.
Data table
| GV — deals by year | |
|---|---|
| 2017 | 4 |
| 2018 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 7 |
| 2022 | 9 |
| 2023 | 3 |
| 2024 | 3 |
| 2025 | 8 |
| 2026 | 7 |
Top sectors
by dealsGV — top sectors — interactive chart.
Data table
| GV — top sectors | |
|---|---|
| Healthtech | 11 |
| Software | 9 |
| AI | 7 |
| Cybersecurity | 4 |
| Energy | 3 |
| Fintech | 3 |
| Cleantech | 2 |
| Consumer | 2 |
| Proptech | 2 |
| Deeptech | 1 |
Stages
by dealsGV — stages — interactive chart.
Data table
| GV — stages | |
|---|---|
| Series A | 12 |
| Other | 10 |
| Series B | 10 |
| Series C | 7 |
| Series D+ | 5 |
| Seed | 1 |
Countries
by dealsGV — countries — interactive chart.
Data table
| GV — countries | |
|---|---|
| UK | 30 |
| Germany | 4 |
| Czech Republic | 2 |
| Israel | 2 |
| Netherlands | 2 |
| Denmark | 1 |
| France | 1 |
| Luxembourg | 1 |
| Switzerland | 1 |
| United States | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared rounds- Accel6
- Lightspeed Venture Partners5
- 20VC4
- Index Ventures3
- Oxford Science Enterprises3
- Seedcamp3
- Alphabet2
- Balderton Capital2
- Blue Venture Fund2
- Boldstart Ventures2
- FirstMark Capital2
- General Catalyst2
- Greycroft Partners2
- Insight Partners2
- Kleiner Perkins2
- Northpond Ventures2
- Point Nine Capital2
- Salesforce Ventures2
- Sanofi Ventures2
- Syncona Partners2
- Thrive Capital2
- Tiger Global2
- 01A1
- Acequia Capital1
- Adams Street Partners1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| Isomorphic Labs | UK | 2 | €2.3B |
| Recursive Superintelligence | UK | 1 | €555M |
| OMass Therapeutics | UK | 2 | €362M |
| Synthesia | UK | 3 | €302M |
| Nothing | UK | 2 | €233M |
| Multiverse | UK | 1 | €205M |
| Genesis | UK | 1 | €176M |
| Leyden Labs | Netherlands | 2 | €164M |
| Scandit | Switzerland | 1 | €131M |
| Tessl | UK | 1 | €119M |
| Ultromics | UK | 2 | €76M |
| GoCardless | UK | 1 | €66M |
| Snyk | UK | 1 | €63M |
| Verve Therapeutics | United States | 1 | €56M |
| Metaview | UK | 1 | €53M |
| Lawhive | UK | 1 | €51M |
| Buena | Germany | 1 | €49M |
| Attio | UK | 1 | €45M |
| SolveAI | UK | 1 | €42M |
| Again | Denmark | 1 | €39M |
| Blockchain | Luxembourg | 1 | €36M |
| Resistant AI | Czech Republic | 2 | €36M |
| Anomali | UK | 1 | €33M |
| Gravity Sketch | UK | 1 | €31M |
| Vacchitech | UK | 1 | €23M |
| Nanit | Israel | 1 | €21M |
| nPlan | UK | 1 | €16M |
| Nym Health | Israel | 1 | €14M |
| Push Security | UK | 1 | €14M |
| deepset | Germany | 1 | €13M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Isomorphic Labs | Series B | €1.8B | 2026-05 |
| Recursive Superintelligence | Other | €555M | 2026-05 |
| Isomorphic Labs | Other | €555M | 2025-03 |
| Multiverse | Series D+ | €205M | 2022-06 |
| Genesis | Series C | €176M | 2022-02 |
| Synthesia | Series D+ | €175M | 2025-01 |
| Nothing | Other | €169M | 2025-09 |
| Scandit | Series D+ | €131M | 2022-02 |
| Leyden Labs | Series B | €124M | 2022-01 |
| Tessl | Series A | €119M | 2024-11 |